IAInes Ayadi

Ines Ayadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ines Ayadi has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diverting Colostomy as a Bridge to Surgery Versus Emergency Primary Resection Without Anastomosis for Obstructive Left‐Sided Colon Cancer

    by Aymen Trigui, Mohammad Saad Saumtally, Moustapha Mohamed Youssouf, Inès Ayadi, Amine Chaabouni, Amine Zouari, Rami Zouari, Salma Ketata, Nozha Toumi, Sami Fendri, et al.

    Background: Malignant left‐sided colon obstruction poses management challenges due to a lack of uniformity in its management. This study aimed to compare outcomes between immediate resection and primary colostomy, focusing on the impact of lymphadenectomy quality and overall survival. The secondary objectives included definitive stoma incidence, duration of stoma, morbidity, hospital stay, and morbidity. Methods: A 7‐year retrospective cross‐sectional study of 127 patients with left colon neoplastic obstruction divided into Primary Resection (PR) and Diverting Stoma (DS) groups was conducted. The characteristics and outcomes of the two groups were compared. Results: Comparisons between the two groups revealed no significant differences in terms of patient characteristics, clinical and radiological signs, or obstruction severity. The DS group exhibited superior resection and lymphadenectomy quality, with more lymph nodes harvested (14.9 ± 1.4 vs. 12.8 ± 1.4, p = 0.012). The PR group had a longer stoma duration (344 ± 1.5 vs. 23.6 ± 1.8 days). The number of permanent stomas was greater in the PR group (42.4%) than in the DS group (9.4%), p < 0.001. The morbidity and mortality rates were similar ( p > 0.05). No overall survival advantage was observed, although DS was associated with increased recurrence‐free survival. Conclusions: Stoma diversion as a bridge to surgery seems to provide better oncological outcomes with improved lymphadenectomy than does emergency resection.

  • Primary Burkitt lymphoma in the posterior mediastinum

    by Zied Chaari, Slim Charfi, Abdessalem Hentati, Ines Ayadi, Hanene Abid, Imed Frikha

    A 13-year-old boy was admitted to our hospital with complaints of posterior chest pain and dyspnea. Computed tomography and magnetic resonance imaging of the chest revealed a mass in the posterior mediastinum, extending from T8 to T11 with intraspinal involvement. A percutaneous core needle biopsy confirmed the diagnosis of Burkitt lymphoma. He was treated according to the Lymphoma Malignancy B protocol 2001 arm C3, but he presented with liver and brain relapses and died 7.5 months after admission. Although lymphoma is rarely localized in the posterior mediastinum, it should be considered in the differential diagnosis of posterior mediastinal masses in children.


  • Prognostic factors and survival in metastatic breast cancer: A single institution experience

    by Afef Khanfir, Faiez Lahiani, Racem Bouzguenda, Ines Ayedi, Jamel Daoud, Mounir Frikha

    The current retrospective study aims to identify some determinants of survival in metastatic breast cancer. The study concerned 332 patients with synchronous (SM) or metachronous (MM) metastatic breast cancer treated between January 2000 and December 2007. Statistical comparison between subgroups of patients concerning survival was carried out employing log-rank test for the invariable analysis and Cox model for the multivariable analysis. Factors included: age group (≤50 years vs. >50; ≤70 years vs. >70; ≤35 years vs. >35), menopausal status, presentation of metastatic disease (SM vs. MM), disease free interval (DFI) (≤24 months vs. >24 months; ≤60 months vs. >60 months), performance status at diagnosis of metastatic disease (PS) (0-1 vs. >1), hormone receptors (HR), number of metastatic sites (1 site vs. >1), nature of the metastatic site (visceral vs. non visceral), first line therapy, surgery of the primary tumor (SPT), locoregional radiotherapy (LRRT) and use or not of bisphosphonates. Overall survival at 5 years was 12%. Positive prognostic factors in univariate analysis were: age ≤ 70 years, hormono-dependence of the tumor, good PS (PS 0-1), less than two metastatic sites, no visceral metastases, DFI ≥ 24 months, SPT or LRRT. In multivariate analysis, favorable independent prognostic factors included: good PS (PS 0-1), absence of visceral metastases (liver, lung, brain) and age ≤ 70 years. Many of the prognostic factors in metastatic breast cancer found in our study are known in the literature but some of them, like the application of locoregional treatment (radiotherapy or surgery) and the use of bisphosphonates, need to be further investigated in randomized clinical trials.